Preview

Experimental and Clinical Gastroenterology

Advanced search

Extrahepatic manifestations of Wilson disease

https://doi.org/10.31146/1682-8658-ecg-234-2-69-77

Abstract

The article presents a brief review of current data on the etiology, pathogenesis, diagnosis and treatment of Wilson disease. Wilson-Konovalov disease (Wilson’s disease, hepatolenticular degeneration, hepatocerebral dystrophy) is a rare severe hereditary autosomal recessive disease caused by homozygous or compound heterozygous mutations (the presence of two different mutant alleles) in the ATP7B gene encoding transmembrane copper-transporting ATPase that mediates the excretion of copper into bile and delivers copper for the synthesis of ceruloplasmin. The article also presents a clinical observation of a young patient with an unrecognized onset of the disease in the form of psychiatric disorders. Subsequently, due to the increase in hepatocellular insufficiency in the form of persistent icteric syndrome, hepatic encephalopathy, decreased protein-synthetic function and coagulation factors, the patient was hospitalized in a multidisciplinary hospital, where a diagnosis of Wilson-Konovalov disease was established.

About the Authors

E. Yu. Kalinina
St. Petersburg State Pediatric Medical University
Russian Federation


A. A. Gnutov
St. Petersburg State Pediatric Medical University
Russian Federation


O. A. Kizimova
St. Petersburg State Pediatric Medical University
Russian Federation


Yu. A. Fominykh
St. Petersburg State Pediatric Medical University; Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Russian Federation


A. D. Tsaregorodtseva
Pavlov First St. Petersburg State Medical University
Russian Federation


E. P. Lykova
St. Petersburg Elizabeth's hospital
Russian Federation


D. R. Zaborovsky
St. Petersburg Elizabeth's hospital
Russian Federation


A. P. Apyakin
St. Petersburg Elizabeth's hospital
Russian Federation


References

1. Narusheniya obmena medi (bolezn’ Vil’sona). Klinicheskie rekomendacii [Disorders of copper metabolism (Wilson’s disease. Clinical guidelines]. (in Russ.) Available at: https://static.edu.rosminzdrav.ru/fc0001/fdpo/decanat/NMO_MZ/TEOC/u14/2024/KR_BV.pdf. Accessed: 02.02.2025.@@ Нарушения обмена меди (болезнь Вильсона). Клинические рекомендации. Доступно на: https://static.edu.rosminzdrav.ru/fc0001/fdpo/decanat/NMO_MZ/TEOC/u14/2024/KR_BV.pdf. Доступ 02.02.2025.

2. Członkowska A., Litwin T., Dusek P. et al. Wilson disease. Nat Rev Dis Primers. 2018 Sep 6;4(1):21. doi: 10.1038/s41572-018-0018-3.

3. Trocello J.M., Broussolle E., Girardot-Tinant N. et al. Wilson’s disease, 100 years later… Rev Neurol (Paris). 2013 Dec;169(12):936-43. doi: 10.1016/j.neurol.2013.05.002.

4. Jayakanthan S., Braiterman L.T., Hasan N.M. et al. Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells. J Biol Chem. 2017 Nov 17;292(46):18760-18774. doi: 10.1074/jbc.M117.807263.

5. Dev S., Kruse R.L., Hamilton J.P., Lutsenko S. Wilson Disease: Update on Pathophysiology and Treatment. Front Cell Dev Biol. 2022 May 2;10:871877. doi: 10.3389/fcell.2022.871877.

6. Teschke R., Eickhoff A. Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.Int J Mol Sci. 2024 Apr 26;25(9):4753. doi: 10.3390/ijms25094753.

7. An Y., Li S., Huang X. et al. The Role of Copper Homeostasis in Brain Disease.Int J Mol Sci. 2022 Nov 10;23(22):13850. doi: 10.3390/ijms232213850.

8. Scheiber I.F., Brůha R., Dušek P. Pathogenesis of Wilson disease. Handb Clin Neurol. 2017;142:43-55. doi: 10.1016/B978-0-444-63625-6.00005-7.

9. Mulligan C., Bronstein J.M. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020 May;38(2):417-432. doi: 10.1016/j.ncl.2020.01.005.

10. Iezzoni J.C. Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol. 2018 Nov;35(6):381-389. doi: 10.1053/j.semdp.2018.10.003.

11. Rowan D.J., Mangalaparthi K.K., Singh S. et al. Metallothionein immunohistochemistry has high sensitivity and specificity for detection of Wilson disease. Mod Pathol. 2022 Jul;35(7):946-955. doi: 10.1038/s41379-021-01001-7.

12. Litwin T., Dusek P., Szafrański T. et al. Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol. 2018 Jul;8(7):199-211. doi: 10.1177/2045125318759461.

13. Hedera P. Wilson’s disease: A master of disguise. Parkinsonism Relat Disord. 2019 Feb;59:140-145. doi: 10.1016/j.parkreldis.2019.02.016.

14. Wungjiranirun M., Sharzehi K. Wilson’s Disease. Semin Neurol. 2023 Aug;43(4):626-633. doi: 10.1055/s-0043-1771465.

15. Kizimova O.A., Fominykh Yu.A., Shotik A.V. Clinical observation of a patient with portal biliopathy against the background of true polycythemia. University Therapeutic Journal. 2023;5(3):144-156. (in Russ.) doi: 10.56871/UTJ.2023.85.51.015.@@ Кизимова О.А., Фоминых Ю.А., Шотик А.В. Клиническое наблюдение пациента с портальной билиопатией на фоне истинной полицитемии. University Therapeutic Journal. 2023;5(3):144-156. doi: 10.56871/UTJ.2023.85.51.015.

16. Grandis D.J., Nah G., Whitman I.R. et al. Wilson’s Disease and Cardiac Myopathy. Am J Cardiol. 2017 Dec 1;120(11):2056-2060. doi: 10.1016/j.amjcard.2017.08.025.

17. Aggarwal A., Bhatt M. Wilson disease. Curr Opin Neurol. 2020 Aug;33(4):534-542. doi: 10.1097/WCO. 0000000000000837.

18. Alkhouri N., Gonzalez-Peralta R.P., Medici V. Wilson disease: a summary of the updated AASLD Practice Guidance. Hepatol Commun. 2023 May 15;7(6): e0150. doi: 10.1097/HC9.0000000000000150.

19. Mudrova A.V., Dreitser E.D., Ivanova E.B. et al. Validated and promising methods of non-invasive diagnostics of liver cirrhosis and its complications. University Therapeutic Bulletin. 2024;6(2):5-13. (in Russ.) doi: 10.56871/UTJ.2024.42.97.001.@@ Мудрова А.В., Дрейцер Е.Д., Иванова Е.Б. и др. Валидированные и перспективные методы неинвазивной диагностики цирроза печени и его осложнений. Университетский терапевтический вестник. 2024;6(2):5-13. doi: 10.56871/UTJ.2024.42.97.001.

20. Mazhar A., Piper M.S. Updates on Wilson disease. Clin Liver Dis (Hoboken). 2023 Oct 2;22(4):117-121. doi: 10.1097/CLD.0000000000000079.

21. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012 Mar;56(3):671-85. doi: 10.1016/j.jhep.2011.11.007.

22. Ferenci P., Caca K., Loudianos G. et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003 Jun;23(3):139-42. doi: 10.1034/j.1600-0676.2003.00824.x.

23. Asanov A. Yu., Sokolov A.A., Volgina S. Ya. et al. [Federal clinical guidelines for the diagnosis and treatment of Wilson-Konovalov disease (hepatolenticular degeneration)]. Moscow: Ministry of Health of the Russian Federation, 2014, 71 p. (in Russ.)@@ Асанов А.Ю., Соколов А.А., Волгина С.Я. и др. Федеральные клинические рекомендации по диагностике и лечению болезни Вильсона-Коновалова (гепатолентикулярная дегенерация). Москва: Министерство здравоохранения Российской Федерации, 2014. - 71 с.


Review

For citations:


Kalinina E.Yu., Gnutov A.A., Kizimova O.A., Fominykh Yu.A., Tsaregorodtseva A.D., Lykova E.P., Zaborovsky D.R., Apyakin A.P. Extrahepatic manifestations of Wilson disease. Experimental and Clinical Gastroenterology. 2025;(2):69-77. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-234-2-69-77

Views: 17


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)